A Study of AGS-16C3F vs. Axitinib in Metastatic Renal Cell Carcinoma (Q63571260)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Study of AGS-16C3F vs. Axitinib in Metastatic Renal Cell Carcinoma |
clinical trial |
Statements
A Multi-Center, Open Label, Randomized Phase 2 Study of AGS-16C3F vs. Axitinib in Metastatic Renal Cell Carcinoma (English)
0 references
24 May 2016
0 references
June 2019
0 references
134
0 references
18 year
0 references